Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
medical imaging technique
|
| gptkbp:administeredBy |
intravenous injection
|
| gptkbp:alternativeName |
18F-FDG PET
FDG PET scan |
| gptkbp:canBe |
lymphoma staging
lung cancer diagnosis melanoma staging brain tumor evaluation colorectal cancer staging Alzheimer's disease assessment cardiac sarcoidosis assessment |
| gptkbp:canDifferentiate |
benign and malignant lesions
|
| gptkbp:combines |
CT
MRI |
| gptkbp:commonIn |
cardiology
neurology oncology |
| gptkbp:contraindication |
pregnant women
patients with high blood glucose |
| gptkbp:cookingMethod |
fasting required
|
| gptkbp:detects |
infection
glucose uptake inflammation metabolic activity myocardial viability tumors epileptic foci |
| gptkbp:fullName |
Fluorodeoxyglucose positron emission tomography
|
| https://www.w3.org/2000/01/rdf-schema#label |
FDG-PET
|
| gptkbp:inventedBy |
1970s
|
| gptkbp:measures |
cellular metabolism
|
| gptkbp:mode |
gptkb:positron_emission_tomography
|
| gptkbp:monitors |
treatment response
|
| gptkbp:practicedWorldwide |
yes
|
| gptkbp:produces |
quantitative data
functional images |
| gptkbp:recognizedBy |
metastatic disease
|
| gptkbp:regulates |
gptkb:FDA
|
| gptkbp:relatedTo |
gptkb:CT_scan
MRI PET scan |
| gptkbp:requires |
gptkb:PET_scanner
Centrifuge radiopharmaceutical |
| gptkbp:usedFor |
cancer diagnosis
cardiac imaging neurological disorder assessment |
| gptkbp:usesIsotope |
gptkb:fluorine-18
|
| gptkbp:usesTracer |
gptkb:fluorodeoxyglucose_(FDG)
|
| gptkbp:bfsParent |
gptkb:PET_scan_with_FDG
|
| gptkbp:bfsLayer |
8
|